Fig. 2From: KIBRA; a novel biomarker predicting recurrence free survival of breast cancer patients receiving adjuvant therapyMicroscopic appearance of IHC staining of breast cancers with KIBRA. a Invasive duct carcinoma with strong (score 3) nuclear and cytoplasmic staining at × 400. b Invasive duct carcinoma with strong (score 3) nuclear and low (score 1) cytoplasmic staining at × 400Back to article page